Cargando…

Guanylate‐binding proteins signature predicts favorable prognosis, immune‐hot microenvironment, and immunotherapy response in hepatocellular carcinoma

BACKGROUND: The role of guanylate‐binding proteins (GBPs) in various cancers has been elucidated recently. However, our knowledge of the clinical relevance and biological characteristics of GBPs in hepatocellular carcinoma (HCC) remains limited. METHODS: A total of 955 HCC patients were enrolled fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Yumei, Fang, Shilin, Fang, Jun, Lin, Kun, Nie, Haihang, Xiong, Peiling, Qiu, Peishan, Zhao, Qiu, Wang, Haizhou, Wang, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501289/ https://www.ncbi.nlm.nih.gov/pubmed/37551111 http://dx.doi.org/10.1002/cam4.6347

Ejemplares similares

Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target
por: Wang, Haizhou, et al.
Publicado: (2022)

Esophagogastroduodenoscopy Outcomes Variated by the Time of the Day: A Single-Center Experience
por: Zhang, Zhang, et al.
Publicado: (2023)

NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma
por: Ning, Yu-Mei, et al.
Publicado: (2022)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
por: Shi, Yuanxin, et al.
Publicado: (2023)

Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response
por: Li, Xiang, et al.
Publicado: (2022)

The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

Consumption of ultra-processed foods and health outcomes: a systematic review of epidemiological studies
por: Chen, Xiaojia, et al.
Publicado: (2020)

A spliceosome-associated gene signature aids in predicting prognosis and tumor microenvironment of hepatocellular carcinoma
por: Wang, Huaxiang, et al.
Publicado: (2023)

N6-Methyladenine-Related Signature for Immune Microenvironment and Response to Immunotherapy in Hepatocellular Carcinoma
por: Ren, Shao-hua, et al.
Publicado: (2022)

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Fang, Chongkai, et al.
Publicado: (2022)

Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma
por: Zheng, Chunlan, et al.
Publicado: (2023)

The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis
por: Wang, Haizhou, et al.
Publicado: (2020)

Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)
por: Bretz, Anne Catherine, et al.
Publicado: (2019)

Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response
por: Ning, Yumei, et al.
Publicado: (2023)

Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma
por: Qi, Xiangjun, et al.
Publicado: (2022)

Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma
por: Zhang, Bo, et al.
Publicado: (2022)

Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer
por: Zhao, Hongying, et al.
Publicado: (2023)

STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment
por: Pu, Zhangya, et al.
Publicado: (2022)

Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma
por: Fang, Guoxu, et al.
Publicado: (2022)

Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma
por: Xue, Weijie, et al.
Publicado: (2023)

An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma
por: Ruan, Wan‐Yuan, et al.
Publicado: (2023)

Immune Microenvironment Terms Signature Robustly Predicts the Prognosis and Immunotherapy Response in Bladder Cancer Based on Large Population Cohorts
por: Liang, Shengjie, et al.
Publicado: (2022)

Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma
por: Wang, Gongjun, et al.
Publicado: (2022)

Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma
por: Lin, Tao, et al.
Publicado: (2022)

Perspectives for immunotherapy of EBV‐associated GLELC: A relatively “hot” tumor microenvironment
por: Lei, Yanna, et al.
Publicado: (2023)

Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis
por: Qiu, Peishan, et al.
Publicado: (2021)

Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature
por: Lu, Lin, et al.
Publicado: (2022)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

YMO1 suppresses invasion and metastasis by inhibiting RhoC signaling and predicts favorable prognosis in hepatocellular carcinoma
por: Chang, Rui-Min, et al.
Publicado: (2016)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

Dynamic RNA 3′ Uridylation and Guanylation during Mitosis
por: Liu, Yusheng, et al.
Publicado: (2020)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response
por: Wu, Yangyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u7v33oflj6l5eft396vq8nbg1q